Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Sep 16:15:219.
doi: 10.1186/s12888-015-0605-8.

Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study

K Aljumah  1 , M A Hassali  2
Affiliations
Randomized Controlled Trial

Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study

K Aljumah et al. BMC Psychiatry. .

Abstract

Background: Adherence to antidepressant treatment is essential for the effective management of patients with major depressive disorder. Adherence to medication is a dynamic decision-making process, and pharmacists play an important role in improving adherence to antidepressant treatment in different settings within the healthcare system. The aim of this study was to assess whether pharmacist interventions based on shared decision making improved adherence and patient-related outcomes.

Methods: This was a randomised controlled study with a 6-month follow-up. Participants were randomly allocated to two groups: 1) intervention group (IG) (usual pharmacy services plus pharmacist interventions based on shared decision making); or 2) control group (CG) (usual pharmacy services). Recruited patients fulfilled the following inclusion criteria: aged 18 to 60 years diagnosed with a major depressive disorder, and no history of psychosis or bipolar disorders. A research assistant blinded to the group allocations collected all data.

Results: Two hundred and thirty-nine patients met the inclusion criteria and were randomised to the IG (n = 119) or CG (n = 120). Nineteen patients dropped out of the study during the follow-up phase. After 6 months, patients in the IG had significantly more favorable medication adherence, treatment satisfaction, general overuse beliefs, and specific concern beliefs. However, the groups did not differ in severity of depression or health-related quality of life after 6 months.

Conclusions: Our findings emphasise the important role of pharmacists in providing direct patient care in regular pharmacy practice to improve adherence to medications and other patient-reported outcomes.

Trial registration: ISRCTN34879893, Date assigned: 30/12/2014.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Recruitment flow diagram
See this image and copyright information in PMC

References

    1. Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Le GM. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav. 2003;7(1):61–72. doi: 10.1023/A:1022513507669. - DOI - PubMed
    1. Sawada N, Uchida H, Suzuki T, Watanabe K, Kikuchi T, Handa T, et al. Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC Psychiatry. 2009;9(1):38. doi: 10.1186/1471-244X-9-38. - DOI - PMC - PubMed
    1. Hunot VM, Horne R, Leese MN, Churchill RC. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Primary Care Companion J Clin Psychiatry. 2007;9(2):91. doi: 10.4088/PCC.v09n0202. - DOI - PMC - PubMed
    1. Al-Jumah KA, Qureshi NA. Impact of pharmacist interventions on patients’ adherence to antidepressants and patient-reported outcomes: a systematic review. Patient Preference and Adherence. 2011;6:87–100. - PMC - PubMed
    1. Benson J, Britten N. Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325(7369):873. doi: 10.1136/bmj.325.7369.873. - DOI - PMC - PubMed

Publication types

Substances

Associated data